Trattamento del "persistent postmastectomy pain" con Lidocaina cerotto 5%

Translated title of the contribution: Treatment of persistent postmastectomy pain with 5% Lidocaine medicated plaster

M. E. Cruto, E. Baricocchi, M. Battistella, F. Bona, G. Giacoletto, A. Iacobellis, N. Moselli, G. Palomba, E. Sardo, M. Savojardo, L. Suita, E. Zocca, F. Debernardi

Research output: Contribution to journalArticlepeer-review


Persistent postmastectomy pain (PPMP) syndrome is characterized by neuropathic pain that develops following surgery in breast cancer patients. The reported incidence of PPMP ranges between 30% and 50% and is estimated to increase as the number of women surviving cancer continues to rise. Though effective, today's drug treatments are poorly tolerated, limiting their use and reducing adherence to therapy. Since neuropathic pain is localized, international guidelines suggest that topical treatment with 5% Lidocaine medicated plaster either alone or combined with systemic drugs can be considered for pain management. In this retrospective study we reviewed the medical records of 11 patients treated with 5% lidocaine medicated plaster for moderate-to-severe PPMP at our institute between November 2013 and October 2014. Analysis showed that treatment with 5% Lidocaine medicated plaster, either alone or in combination with systemic drugs, achieved significant pain control already after the first week of therapy. The effectiveness and tolerability of 5% Lidocaine medicated plaster we observed suggests that it is a viable option in the management of PPMP.

Translated title of the contributionTreatment of persistent postmastectomy pain with 5% Lidocaine medicated plaster
Original languageItalian
Pages (from-to)147-153
Number of pages7
JournalMinerva Chirurgica
Issue number2
Publication statusPublished - Apr 1 2015

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Treatment of persistent postmastectomy pain with 5% Lidocaine medicated plaster'. Together they form a unique fingerprint.

Cite this